Injective vs Telcoin — how do they compare? Injective trades at Rp92,485 (market cap Rp9,38T, Rp1,76T 24h volume), while Telcoin trades at Rp37.28 (market cap Rp3,64T, Rp15,87M 24h volume). The key difference: Injective is far larger — about 2.6× Telcoin's market cap, and Telcoin's supply is capped (96,1B / 100B TEL (97%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Telcoin for 11 Days on average.
| INJ | TEL | |
|---|---|---|
Market Cap | Rp9,38T | Rp3,64T |
Volume (24h) | Rp1,76T | Rp15,87M |
Circulating Supply | 100M INJ | 96,1B / 100B TEL (97%) |
Typical Hold Time | 36 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Telcoin (TEL) is currently trading at Rp37.507 with a market cap of Rp3.59T, showing a bearish technical signal as indicated by moving averages. The token is near support at Rp37, with RSI_6 at 22.07 suggesting potential oversold conditions. Recent on-chain data shows a high circulation rate of 97% and an average hold time of 11 days, indicating active trading but limited long-term holding.
Overall outlook remains cautious due to bearish technicals, though oversold RSI may present a short-term opportunity. Key risks include high volatility and regulatory uncertainty in the crypto space. Investors should monitor support levels and broader market sentiment for entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Telcoin, launched in 2017 and governed by the Telcoin Association, is a fintech operating in 171 countries. It combines blockchain, telecommunications, and digital banking to offer affordable financial services. The Telcoin Wallet supports over 100 digital assets and enables global remittances. Telcoin is regulated as a Virtual Asset Service Provider in the EU and Argentina, a Major Payment Institution in Singapore, and a Money Services Business in several countries.
Read more on TEL →